James P. Long, PhD
Department of Biostatistics, Division of Discovery Science
About James P. Long
PlainBashC++C#CSSDiffHTML/XMLJavaJavaScriptMarkdownPHPPythonRubySQLJames P. Long is an Associate Professor of Biostatistics. Please visit his personal website at
https://longjp.github.io/
Read More
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Biostatistics, Division of Discovery Science, University of Texas MD Anderson Cancer Center, Houston, TX
Adjunct Associate Professor, Department of Statistics, Rice University, Houston, TX
Associate Professor, Department of Quantitative Sciences, Graduate School of Biological Sciences, Houston, TX
Education & Training
Degree-Granting Education
| 2013 | University of California, Berkeley, Berkeley, California, US, Statistics, Ph.D |
| 2008 | Columbia University, New York, New York, US, Mathematics and Statistics, BA |
Experience & Service
Academic Appointments
Adjunct Assistant Professor, Department of Statistics, Texas A&M University, College Station, TX, 2018 - 2020
Assistant Professor, Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2024
Research Fellow, Statistical and Applied Mathematical Sciences Institute, Research Triangle Park, NC, 2016 - 2016
Assistant Professor, Department of Statistics, Texas A&M University, College Station, TX, 2013 - 2018
Institutional Committee Activities
Associate Member, IRB5, 2019 - Present
Associate Member, DSMB, 2019 - 2022
Senator, Faculty Senate, 2015 - 2018
Honors & Awards
| 2017 | Korean International Statistics Society Career Development Award, Korean International Statistics Society |
| 2012 | Citadel Fellowship, Citadel LLC |
Selected Publications
Peer-Reviewed Articles
- Gendarme S, Irajizad E, Long JP, Fahrmann JF, Dennison JB, Ghasemi SM, Dou R, Volk RJ, Meza R, Toumazis I, Canoui-Poitrine F, Hanash SM, Ostrin EJ. Impact of comorbidities on the mortality benefits of lung cancer screening: a post-hoc analysis of PLCO and NLST trials. J Thorac Oncol, 2025. e-Pub 2025. PMID: 39798695.
- Fahrmann JF, Yip-Schneider M, Vykoukal J, Spencer R, Dennison JB, Do KA, Long JP, Maitra A, Zhang J, Schmidt CM, Hanash S, Irajizad E. Lead time trajectory of blood-based protein biomarkers for detection of pancreatic cancer based on repeat testing. Cancer Lett 612:217450, 2025. e-Pub 2025. PMID: 39793753.
- Long JP, Yang Y, Shimizu S, Pham T, Do KA. Causal models and prediction in cell line perturbation experiments. BMC Bioinformatics 26(1):4, 2025. e-Pub 2025. PMID: 39773352.
- Burk KJ, Stroh JJ, Larkin K, Chaftari P, Langabeer DM, Menendez JR, Woodruff JF, Hargrave J, Zhu H, Long JP, Yeung SJ, Alagappan K, Qdaisat A. Empathy Unmasked: Patient Perception of Physician Empathy in an Oncologic Emergency Setting. A Randomized Controlled Trial Comparing Personal Protective Equipment Wear versus Unmasked Video Communication. J Emerg Med 68:43-53, 2025. e-Pub 2025. PMID: 39800593.
- Ghasemi SM, Gu C, Fahrmann JF, Hanash S, Do KA, Long JP, Irajizad E. A Novel Sensitivity Maximization at a Given Specificity Method for Binary Classifications. Cancer Prev Res (Phila), 2024. e-Pub 2024. PMID: 39618306.
- Gule-Monroe M, Chasen N, Long JP, Kumar VA, Shah K, Chen M, Stafford J, Chung C, Wintermark M, Hou P, Sura E, Wang C, Weinberg J, Liu HL. Diagnostic Confidence of Contrast-Enhanced T1-Weighted MRI for the Detection of Brain Metastases: 3D FSE-vs. 3D GRE-Based Sequences. AJNR Am J Neuroradiol, 2024. e-Pub 2024. PMID: 39572196.
- Muthusivarajan R, Celaya A, Yung JP, Long JP, Viswanath SE, Marcus DS, Chung C, Fuentes D. Evaluating the relationship between magnetic resonance image quality metrics and deep learning-based segmentation accuracy of brain tumors. Med Phys 51(7):4898-4906, 2024. e-Pub 2024. PMID: 38640464.
- Campbell MT, Balderrama-Brondani V, Jimenez C, Tamsen G, Marcal LP, Varghese J, Shah AY, Long JP, Zhang M, Ochieng J, Haymaker C, Habra MA. Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial. Lancet Oncol 25(5):649-657, 2024. e-Pub 2024. PMID: 38608694.
- Jimenez C, Habra MA, Campbell MT, Tamsen G, Cruz-Goldberg D, Long JP, Bassett R, Dantzer R, Balderrama-Brondani V, Varghese J, Lu Y. Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial. Lancet Oncol 25(5):658-667, 2024. e-Pub 2024. PMID: 38608693.
- Arthur J, Edwards T, Lu Z, Amoateng MD, Koom-Dadzie K, Zhu H, Long JP, Do KA, Bruera E. Healthcare provider perceptions and reported practices regarding opioid prescription for patients with chronic cancer pain. Support Care Cancer 32(2):121, 2024. e-Pub 2024. PMID: 38252311.
- Zhang X, Irajizad E, Hoffman KL, Fahrmann JF, Li F, Seo YD, Browman GJ, Dennison JB, Vykoukal J, Luna PN, Siu W, Wu R, Murage E, Ajami NJ, McQuade JL, Wargo JA, Long JP, Do KA, Lampe JW, Basen-Engquist KM, Okhuysen PC, Kopetz S, Hanash SM, Petrosino JF, Scheet P, Daniel CR. Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial. EBioMedicine 98, 2023. e-Pub 2023. PMID: 38040541.
- Buszek SM, Tran B, Long JP, Luo D, Suki D, Li J, Ferguson S, Chung C. Postoperative Management of Recurrence After Radiosurgery and Surgical Resection for Brain Metastases and Predicting Benefit From Adjuvant Radiation. Pract Radiat Oncol 13(6):e499-e503, 2023. e-Pub 2023. PMID: 37295724.
- Long JP, Zhu H, Do KA, Ha MJ. Estimating Causal Effects with Hidden Confounding using Instrumental Variables and Environments. Electronic Journal of Statistics 17(2), 2023. e-Pub 2023. PMID: 38957485.
- Irajizad E, Fahrmann JF, Marsh T, Vykoukal J, Dennison JB, Long JP, Do KA, Feng Z, Hanash S, Ostrin EJ. Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort. J Clin Oncol 41(27):4360-4368, 2023. e-Pub 2023. PMID: 37379494.
- Irajizad E, Kenney A, Tang T, Vykoukal J, Wu R, Murage E, Dennison JB, Sans M, Long JP, Loftus M, Chabot JA, Kluger MD, Kastrinos F, Brais L, Babic A, Jajoo K, Lee LS, Clancy TE, Ng K, Bullock A, Genkinger JM, Maitra A, Do KA, Yu B, Wolpin BM, Hanash S, Fahrmann JF. A blood-based metabolomic signature predictive of risk for pancreatic cancer. Cell Rep Med 4(9):101194, 2023. e-Pub 2023. PMID: 37729870.
- Long JP, Shen Y. Detection method has independent prognostic significance in the PLCO lung screening trial. Sci Rep 13(1):13382, 2023. e-Pub 2023. PMID: 37591907.
- Huang L, Long JP, Irajizad E, Doecke JD, Do KA, Ha MJ. A unified mediation analysis framework for integrative cancer proteogenomics with clinical outcomes. Bioinformatics 39(1), 2023. e-Pub 2023. PMID: 36648331.
- Singh S, Long JP, Tchakarov A, Dong Y, Yee C, Lin JS. Tertiary lymphoid structure signatures are associated with immune checkpoint inhibitor related acute interstitial nephritis. JCI Insight, 2022. e-Pub 2022. PMID: 36472921.
- Lopez BP, Mahvash A, Long JP, MGEH L, Kappadath SC. Factors modulating 99m Tc-MAA planar lung dosimetry for 90 Y radioembolization. J Appl Clin Med Phys 23(12), 2022. e-Pub 2022. PMID: 35906892.
- Irajizad E, Han CY, Celestino J, Wu R, Murage E, Spencer R, Dennison JB, Vykoukal J, Long JP, Do KA, Drescher C, Lu K, Lu Z, Bast RC, Hanash S, Fahrmann JF. A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses. Clinical Cancer Research 28(21):4669-4676, 2022. e-Pub 2022. PMID: 36037307.
- Gates EDH, Suki D, Celaya A, Weinberg JS, Prabhu SS, Sawaya R, Huse JT, Long JP, Fuentes D, Schellingerhout D. Cellular Density in Adult Glioma, Estimated with MR Imaging Data and a Machine Learning Algorithm, Has Prognostic Power Approaching World Health Organization Histologic Grading in a Cohort of 1181 Patients. AJNR Am J Neuroradiol 43(10):1411-1417, 2022. e-Pub 2022. PMID: 36109124.
- Singh S, Clemente LC, Parra ER, Tchakarov A, Yang C, Li Y, Long JP, Yee C, Lin JS. Urinary T cells are detected in patients with immune checkpoint inhibitor-associated immune nephritis that are clonotypically identical to kidney T cell infiltrates. Oncoimmunology 11(1), 2022. e-Pub 2022. PMID: 36185804.
- Irajizad E, Fahrmann JF, Long JP, Vykoukal J, Kobayashi M, Capello M, Yu CY, Cai Y, Hsiao FC, Patel N, Park S, Peng Q, Dennison JB, Kato T, Tai MC, Taguchi A, Kadara H, Wistuba II, Katayama H, Do KA, Hanash SM, Ostrin EJ. A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response. Int J Mol Sci 23(16), 2022. e-Pub 2022. PMID: 36012199.
- Soundararajan R, Viscuse P, Pilie P, Liu J, Logotheti S, Laberiano Fernández C, Lorenzini D, Hoang A, Lu W, Soto LMS, Wistuba II, Xu M, Song X, Shepherd PDA, Navone NM, Tidwell RSS, Lozano G, Logothetis C, Zhang J, Long JP, Estecio MR, Tzelepi V, Aparicio AM. Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) Components. Cancers (Basel) 14(13), 2022. e-Pub 2022. PMID: 35805010.
- Groot J, Ott M, Wei J, Kassab C, Fang D, Najem H, O'Brien B, Weathers SP, Matsouka CK, Majd NK, Harrison RA, Fuller GN, Huse JT, Long JP, Sawaya R, Rao G, MacDonald TJ, Priebe W, DeCuypere M, Heimberger AB. A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma. CNS Oncology 11(2), 2022. e-Pub 2022. PMID: 35575067.
- Najem H, Ott M, Kassab C, Rao A, Rao G, Marisetty A, Sonabend AM, Horbinski C, Verhaak R, Shankar A, Krishnan SN, Varn FS, Arrieta VA, Gupta P, Ferguson SD, Huse JT, Fuller GN, Long JP, Winkowski DE, Freiberg BA, James CD, Platanias LC, Lesniak MS, Burks JK, Heimberger AB. Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression. JCI Insight 7(9), 2022. e-Pub 2022. PMID: 35316217.
- Gupta AC, Owens CA, Shrestha S, Lee C, Smith SA, Weathers RE, Netherton T, Balter PA, Kry SF, Followill DS, Griffin KT, Long JP, Armstrong GT, Howell RM. Body Region-Specific 3D Age-Scaling Functions for Scaling Whole-Body Computed Tomography Anatomy for Pediatric Late Effects Studies. Biomed Phys Eng Express 8(2), 2022. e-Pub 2022. PMID: 34874300.
- Long JP, Ha MJ. Sample selection bias in evaluation of prediction performance of causal models. Statistical Analysis and Data Mining 15(1):5-14, 2022. e-Pub 2022. PMID: 35498876.
- Wei J, Song R, Sabbagh A, Marisetty A, Shukla N, Fang D, Najem H, Ott M, Long JP, Zhai L, Lesniak MS, James CD, Platanias L, Curran M, Heimberger AB. Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system. Oncoimmunology 11(1), 2022. e-Pub 2022. PMID: 35433114.
- Semba T, Wang X, Xie X, Cohen EN, Reuben JM, Dalby KN, Long JP, Hanh Phi LT, Tripathy D, Ueno NT. Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated with an Immunosuppressive Tumor Microenvironment. J Natl Cancer Inst 114(1):97-108, 2022. e-Pub 2022. PMID: 34250544.
- Irajizad E, Wu R, Vykoukal J, Murage E, Spencer R, Dennison JB, Moulder S, Ravenberg E, Lim B, Litton J, Tripathym D, Valero V, Damodaran S, Rauch GM, Adrada B, Candelaria R, White JB, Brewster A, Arun B, Long JP, Do KA, Hanash S, Fahrmann JF. Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Frontiers in Artificial Intelligence 5:876100, 2022. e-Pub 2022. PMID: 36034598.
- Teyateeti A, Mahvash A, Long JP, Abdelsalam M, Avritscher R, Kaseb A, Odisio B, Ravizzini G, Surasi D, Teyateeti A, Macapinlac H, Kappadath SC. Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib. World J Gastroenterol 27(47):8166-8181, 2021. e-Pub 2021. PMID: 35068861.
- Najem H, Marisetty A, Horbinski C, Long JP, Huse JT, Glitza Oliva IC, Ferguson SD, Kumthekar PU, Wainwright DA, Chen P, Lesniak MS, Burks JK, Heimberger AB. CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease. Front Immunol 12:745893, 2021. e-Pub 2021. PMID: 34691054.
- Katayama H, Kobayashi M, Irajizad E, Sevillarno A, Patel N, Mao X, Rusling L, Vykoukal J, Cai Y, Hsiao F, Yu CY, Long JP, Liu J, Esteva F, Fahrmann J, Hanash S. Protein citrullination as a source of cancer neoantigens. J Immunother Cancer 9(6), 2021. e-Pub 2021. PMID: 34112737.
- Chainitikun S, Espinosa Fernandez JR, Long JP, Iwase T, Kida K, Wang X, Saleem S, Lim B, Valero V, Ueno NT. Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review. PLoS One 16(4):e0250057, 2021. e-Pub 2021. PMID: 33861773.
- Fahrmann JF, Schmidt CM, Mao X, Irajizad E, Loftus M, Zhang J, Patel N, Vykoukal J, Dennison JB, Long JP, Do KA, Zhang J, Chabot JA, Kluger MD, Kastrinos F, Brais L, Babic A, Jajoo K, Lee LS, Clancy TE, Ng K, Bullock A, Genkinger J, Yip-Schneider MT, Maitra A, Wolpin BM, Hanash S. Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection. Gastroenterology 160(4):1373-1383.e6, 2021. e-Pub 2021. PMID: 33333055.
- Fahrmann JF, Irajizad E, Kobayashi M, Vykoukal J, Dennison JB, Murage E, Wu R, Long JP, Do KA, Celestino J, Lu KH, Lu Z, Bast RC, Hanash S. A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer. Cancers (Basel) 13(4):1-22, 2021. e-Pub 2021. PMID: 33671595.
- Ferguson SD, Hodges TR, Majd NK, Alfaro-Munoz K, Al-Holou WN, Suki D, de Groot JF, Fuller GN, Xue L, Li M, Jacobs C, Rao G, Colen RR, Xiu J, Verhaak R, Spetzler D, Khasraw M, Sawaya R, Long JP, Heimberger AB. A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram. Neuro-Oncology Advances 3(1), 2021. e-Pub 2021. PMID: 33426529.
- Capello M, Fahrmann JF, Rios Perez MV, Vykoukal JV, Irajizad E, Tripathi SC, Roife D, Bantis LE, Kang Y, Kundnani DL, Xu H, Prakash LR, Long JP, Katayama H, Fleury A, Ferri-Borgogno S, Baluya DL, Dennison JB, Aguilar-Bonavides C, Casabar JP, Celiktas M, Do KA, Fiehn O, Maitra A, Wang H, Feng Z, Chiao PJ, Katz MH, Fleming JB, Hanash SM. CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes. JCO Precis Oncol 4:426-436, 2020. e-Pub 2020. PMID: 35050739.
- Ott M, Tomaszowski KH, Marisetty A, Kong LY, Wei J, Duna M, Blumberg K, Ji X, Jacobs C, Fuller GN, Langford LA, Huse JT, Long JP, Hu J, Li S, Weinberg JS, Prabhu SS, Sawaya R, Ferguson S, Rao G, Lang FF, Curran MA, Heimberger AB. Glioma patient profiling reveals the dominant immune suppressive adenosine axis is refractory to immune function restoration. JCI Insight 5(17), 2020. e-Pub 2020. PMID: 32721947.
- Rao G, Latha K, Ott M, Sabbagh A, Marisetty A, Ling X, Zamler D, Doucette TA, Yang Y, Kong LY, Wei J, Fuller GN, Benavides F, Sonabend AM, Long JP, Li S, Curran M, Heimberger AB. Anti-PD-1 induces M1 polarization in the glioma microenvironment and exerts therapeutic efficacy in the absence of CD8 cytotoxic T cells. Clin Cancer Res 26(17):4699-4712, 2020. e-Pub 2020. PMID: 32554515.
- Chainitikun S, Long JP, Rodriguez-Bautista R, Iwase T, Tripathy D, Fujii T, Ueno NT. The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. Breast Cancer Res Treat, 2020. e-Pub 2020. PMID: 32720114.
- Ott M, Kassab C, Marisetty A, Hashimoto Y, Wei J, Zamler DB, Leu JS, Tomaszowski KH, Sabbagh A, Fang D, Gupta P, Priebe W, Zielinski R, Burks JK, Long JP, Kong LY, Fuller GN, de Groot JF, Sulman EP, Heimberger AB. Radiation with STAT3 blockade triggers dendritic cell-T cell interactions in the glioma microenvironment and therapeutic efficacy. Clin Cancer Res, 2020. e-Pub 2020. PMID: 32605912.
- Amin SB, Anderson KJ, Boudreau CE, Martinez-Ledesma E, Kocakavuk E, Johnson KC, Barthel FP, Varn FS, Kassab C, Ling X, Kim H, Barter M, Lau CC, Ngan CY, Chapman M, Koehler JW, Long JP, Miller AD, Miller CR, Porter BF, Rissi DR, Mazcko C, LeBlanc AK, Dickinson PJ, Packer RA, Taylor AR, Rossmeisl JH, Woolard KD, Heimberger AB, Levine JM, Verhaak RGW. Comparative Molecular Life History of Spontaneous Canine and Human Gliomas. Cancer Cell 37(2):243-257.e7, 2020. e-Pub 2020. PMID: 32049048.
- Kobayashi M, Katayama H, Irajizad E, Vykoukal JV, Fahrmann JF, Kundnani DL, Yu CY, Cai Y, Hsiao FC, Yang WL, Lu Z, Celestino J, Long JP, Do KA, Lu KH, Ladd JJ, Urban N, Bast RC, Hanash SM. Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis. Cancers (Basel) 12(2), 2020. e-Pub 2020. PMID: 32092936.
- Yi X, Sarkar A, Kismali G, Aslan B, Ayres M, Iles LR, Keating MJ, Wierda W, Long JP, Bertilaccio MTS, Gandhi V. AMG-176, an Mcl-1 antagonist, shows preclinical efficacy in chronic lymphocytic leukemia. Clin Cancer Res, 2020. e-Pub 2020. PMID: 31937611.
- Lin Z, Long JP. A Flexible Procedure for Mixture Proportion Estimation in Positive-Unlabeled Learning. Data Mining and Statistical Learning 13:178-187, 2020. e-Pub 2020.
- Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Teyateeti A, Macapinlac HA, Kappadath SC. Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients. J Hepatocell Carcinoma 7:117-131, 2020. e-Pub 2020. PMID: 32984089.
- Fahrmann JF, Vykoukal J, Fleury A, Tripathi S, Dennison JB, Murage E, Wang P, Yu CY, Capello M, Creighton CJ, Do KA, Long JP, Irajizad E, Peterson C, Katayama H, Disis ML, Arun B, Hanash S. Association between plasma diacetylspermine and tumor spermine synthase with outcome in triple negative breast cancer. J Natl Cancer Inst 112(6):607-616, 2019. e-Pub 2019. PMID: 31503278.
- Stringer K, Long J, Macri L, Marshall J, et al. Identification of RR Lyrae Stars in Multiband, Sparsely Sampled Data from the Dark Energy Survey Using Template Fitting and Random Forest Classification. The Astronomical Journal 158(1):16, 2019. e-Pub 2019.
- Yan Y, Sun N, Wang H, Kobayashi M, Ladd JJ, Long JP, Lo KC, Patel J, Sullivan E, Albert T, Goodman GE, Do KA, Hanash SM. Whole Genome-Derived Tiled Peptide Arrays Detect Prediagnostic Autoantibody Signatures in Non-Small-Cell Lung Cancer. Cancer Res 79(7):1549-1557, 2019. e-Pub 2019. PMID: 30723114.
- Long JP, de Souza RS. Statistical Methods in Astronomy. Wiley StatsRef, 2018. e-Pub 2018.
- Yuan W, He S, Macri LM, Long JP, Huang JZ. The M33 Synoptic Stellar Survey. II. Mira Variables. The Astrophysical Journal 153(4):Article Number 170, 2017. e-Pub 2017.
- Long JP. A note on parameter estimation for misspecified regression models with heteroskedastic errors. Electronic Journal of Statistics 11(1):1464-1490, 2017. e-Pub 2017.
- He S, Yuan W, Huang JZ, Long JP, Macri LM. Period Estimation for Sparsely Sampled Quasi-Periodic Light Curves Applied to Miras. The Astrophysical Journal 152(6):Article Number 164, 2016. e-Pub 2016.
- Salmon B, Papovich C, Long JP, Willner SP, Finkelstein SL, Ferguson HC, Dickinson M, Duncan K, Faber SM, Hathi N, Perez-Gonzalez PG, Pforr J. A Bayesian Approach to Reveal the Non-Universality of the Dust-Attenuation Law at High Redshift. The Astrophysical Journal 827(1):Article Number 20, 2016. e-Pub 2016.
- Long JP, El Karoui N, Rice JA. Kernel Density Estimation with Berkson Error. The Canadian Journal of Statistics 44(2):142-160, 2016. e-Pub 2016.
- Long JP, Chi E, Baraniuk R. Estimating a common period for a set of irregularly sampled functions with applications to periodic variable star data. Annals of Applied Statistics 10(1):165-197, 2016. e-Pub 2016.
- Mondrik N, Long JP, Marshall J. A multiband generalization of the multiharmonic analysis of variance period estimation algorithm and the effect of inter-band observing cadence on period recovery rate. Astrophysical Journal Letters 811(2):Article Number L34, 2015. e-Pub 2015.
- Salmon B, Papovich C, Finkelstein SL, Tilvi V, Finlator K, Behroozi P, Dahlen T, Dave R, Dekel A, Dickinson M, Ferguson HC, Giavalisco M, Long JP, Lu Y, Mobasher B, Reddy N, Somerville RS, Wechsler RH. The Relation Between Star Formation Rate and Stellar Mass for Galaxies at 3.5 < z < 6.5 in CANDELS. The Astrophysical Journal 799(2):Article Number 183, 2015. e-Pub 2015.
- Tilvi V, Papovich C, Finkelstein SL, Long JP, Song M, Dickinson M, Ferguson HC, Koekemoer AM, Giavalisco M, Mobasher B. Rapid Decline of Ly-alpha Emission toward the Reionization Era. The Astrophysical Journal, 2014. e-Pub 2014.
- Long JP, El Karoui N, Rice JA, Richards JW, Bloom JS. Optimizing Automated Classification of variable Stars in new synoptic surveys. Publications of the Astronomical Society of the Pacific 124(913):280-295, 2012. e-Pub 2012.
- Morgan AN, Long JP, Richards JW, Broderick T, Butler NR, Bloom JS. Rapid,machine-learned resource allocation: Application to high-redshift GRB follow-up. The Astrophysical Journal, 2012. e-Pub 2012.
- Richards JW, Starr DL, Brink H, Miller AA, Bloom JS, Butler NR, James JB, Long JP, Rice JA. Active learning to overcome sample selection bias: Application to photometric variable star classification. The Astrophysical Journal, 2012. e-Pub 2012.
- Kinirons P, Rabinowitz D, Gravel M, Long JP, Winawer M, Senechal G, Ottman R, Cossette P. Phenotypic concordance in 70 families with ige-implications for genetic studies of epilepsy. Epilepsy Research 82(1):21-28, 2008. e-Pub 2008.
Book Chapters
- Long JP, Jack LJ. Inferential Frameworks for Clinical Trials. In: Principles and Practice of Clinical Trials. Springer, 2020.
- Long JP, Bloom JS, El Karoui N, Rice JA, and Richards JW. Classification of poorly time sampled light curves of periodic variable stars. In: In Astrostatistics and Data Mining. Springer International Publishing, 163-171, 2012.
Selected Presentations & Talks
Local Presentations
- 2024. Causal Discovery and Prediction with Interventional Data: Application to Cell Perturbation Experiments. Invited. Houston, Texas, US.
- 2023. Prognostic Models in Oncology: From Feature Selection to Web Apps. Invited. San Antonio, TX, US.
- 2023. Causal Discovery and Prediction with Interventional Data: Application to Cell Perturbation Experiments. Invited. Hikone, Shiga, JP.
- 2021. Collaborating with Biostatisticians. Invited. Houston, TX, US.
- 2020. Causal Mediation Analysis with Non-linear Models, Multiple Mediators, and DAGs. Invited. Dallas, TX, US.
- 2019. Advances in Mediation Analysis: Non-linear Models, Multiple Mediators, and Causal DAGs. Invited. Houston, TX, US.
- 2017. Mapping the Milky Way Halo: Modeling and Classifying Vector Valued Functions. Invited. Waco, TX, US.
- 2016. Statistical Tools for Time Domain Astronomy. Invited. Chapel Hill, NC, US.
- 2014. Period Estimation for Multiband Variable Stars. Invited. College Station, TX, US.
- 2014. Estimating a Common Period for a Set of Irregularly Sampled Functions with Applications to Astronomy Data. Invited. Houston, TX, US.
- 2013. Classification of Sparse, Irregularly Sampled Time Series and Heterogeneous Feature Noise. Invited. Pittsburgh, PA, US.
- 2013. Classification of Sparse, Irregularly Sampled Time Series and Heterogeneous Feature Noise. Invited. College Station, TX, US.
- 2013. Classification of Sparse, Irregularly Sampled Time Series and Heterogeneous Feature Noise. Invited. Davis, CA, US.
Regional Presentations
- 2022. Causal Models, Prediction, and Extrapolation in Cell Line Perturbation Experiments. Conference. Texas A&M Department of Statistics. College Station, TX, US.
- 2015. Automated Classification of Variable Stars: Methods and Challenges. Conference. Indo - US Workshop on Advances in Variable Star Research. Woodlands, TX, US.
- 2015. Estimating a Common Period for a Set of Irregularly Sampled Functions with Applications to Astronomy Data. Conference. Council of Texas Statisticians. Austin, TX, US.
- 2015. Incorporating Photometric Uncertainty Into Misspecified Models. Conference. Building Astronomy In Texas Organizing Committee. College Station, TX, US.
National Presentations
- 2024. Causal Inference with Hidden Confounders: Instrumental Variables and the Generalized Causal Dantzig. Conference. WNAR. Fort Collins, Colorado, US.
- 2023. Causal Discovery and Prediction with Interventional Data: Application to Cell Perturbation Experiments. Conference. ACIC. Austin, TX, US.
- 2022. Causal Inference with Hidden Confounders: Instrumental Variables and the Generalized Causal Dantzig. Conference. ENAR. Houston, TX, US.
- 2020. Mixture Proportion Estimation in Positive–Unlabeled Learning. Conference. ENAR. Nashville (Virtual), TN, US.
- 2018. Mapping the Milky Way Halo with the Dark Energy Survey. Conference. American Association for the Advancement of Science. Austin, TX, US.
- 2016. Discovery and Characterization of RR Lyrae from Sparsely Sampled Light Curves Using Parsimonious Models. Invited. Statistical Challenges in Modern Astronomy VI. Pittsburgh, PA, US.
- 2015. Period Luminosity Relations and Gaussian Processes for Period Estimation. Invited. Joint Statistical Meetings. Seattle, WA, US.
- 2014. Kernel Density Estimation with Berkson Error. Invited. Joint Statistical Meetings. Boston, MA, US.
International Presentations
- 2021. Causal Inference with Hidden Confounders: A comparison between Two Stage Least Squares and the Causal Dantzig. Invited. EcoSta. Hong Kong, HK.
- 2017. Mapping the Milky Way Halo: Modeling and Classifiying Vector Valued Functions. Invited. Data Science, Statistics, and Visualization. Lisbon, PT.
- 2017. Two Statistical Challenges in Classification of Variable Sources. Invited. Time Series Analysis for Synoptic Surveys and Gravitational Wave Astronomy. Bengaluru, IN.
Grant & Contract Support
| Date: | 2024 - 2029 |
| Title: | Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC) |
| Funding Source: | NIH/NCI |
| Role: | Statistician |
| ID: | R01 CA283402-01A1 |
| Date: | 2024 - 2025 |
| Title: | Development of a Novel Tumor-targeting and Penetrating Nanosystem for Breast Cancer Therapy |
| Funding Source: | Department of Defense (DOD) |
| Role: | Co-PI |
| ID: | BC190193P1 |
| Date: | 2023 - 2028 |
| Title: | Developing a novel combination immunotherapy for triple-negative breast cancer |
| Funding Source: | University of Hawaii Cancer Center Subaward-Subcontract |
| Role: | Co-I |
| ID: | 1R01CA278056-01A1 |
| Date: | 2022 - 2025 |
| Title: | Delineating germline, tumor and extrinsic factors driving mucosal melanoma risk and response |
| Funding Source: | US Department of Defense |
| Role: | Co-I |
| ID: | W81XWH2210973 |
| Date: | 2022 - 2027 |
| Title: | Targeting Acquired Resistance in KRAS Driven Cancers |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R37CA272744-01 |
| Date: | 2022 - 2026 |
| Title: | Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R01CA257842-01A1 |
| Date: | 2022 - 2027 |
| Title: | Deep learning microscope for slide-free and digital histology |
| Funding Source: | NIH/NIDCR subaward via William Marsh Rice University |
| Role: | Co-I |
| ID: | 1R01DE032051-01 |
| Date: | 2022 - 2027 |
| Title: | A Phase II Study to evaluate the efficacy and safety of pembrolizumab in combination with mitotane in patients with advanced adrenocortical carcinoma |
| Funding Source: | NIH/NCI |
| Role: | Statistician |
| ID: | #TBA |
| Date: | 2022 - 2025 |
| Title: | IRE-based Rational Combination for Effective PDAC Immunotherapy |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | RP220051 |
| Date: | 2021 - 2024 |
| Title: | RA200128: Enhancing Axl-targeted therapy in inflammatory breast cancer |
| Funding Source: | US Department of Defense |
| Role: | Co-I |
| ID: | RA200128 |
| Date: | 2021 - 2026 |
| Title: | Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 5R01CA258540-02 |
| Date: | 2021 - 2026 |
| Title: | Mechanisms associated with organotropic metastasis |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 5R01CA252729-02 |
| Date: | 2021 - 2026 |
| Title: | Investigation of the role of epithelial-mesenchymal plasticity in renal cell carcinoma |
| Funding Source: | NIH/NCI |
| Role: | Biostatistician |
| ID: | 5R01CA258226-02 |
| Date: | 2021 - 2026 |
| Title: | Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer |
| Funding Source: | NIH/NCI subaward via Indiana University |
| Role: | Co-I |
| ID: | 1 U01 CA239522-01A1 |
| Date: | 2020 - 2024 |
| Title: | Chemoimmunotherapy for Aggressive Variant Prostate Cancers (AVPC) |
| Funding Source: | Department of Defense (DOD) |
| Role: | Statistician |
| ID: | PC190353 |
| Date: | 2020 - 2025 |
| Title: | Precision Optical Guidance for Oral Biopsy Based on Next-Generation Hallmarks of Cancer |
| Funding Source: | NIH/NIDCR Subaward Rice University |
| Role: | Biostatistician |
| ID: | 5R01DE029590-03 |
| Date: | 2019 - 2026 |
| Title: | Cancer Center Support Grant (CCSG) - Biostatistics Resource Group (BRG) |
| Funding Source: | NIH/NCI |
| Role: | Biostatistician |
| ID: | 5P30CA016672-46 |
Patient Reviews
CV information above last modified March 19, 2025